PDB Short entry for 1F2H HEADER APOPTOSIS 24-MAY-00 1F2H TITLE SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE TNFR1 ASSOCIATED TITLE 2 PROTEIN, TRADD. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUMOR NECROSIS FACTOR RECEPTOR TYPE 1 ASSOCIATED DEATH COMPND 3 DOMAIN PROTEIN; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: N-TERMINAL DOMAIN; COMPND 6 SYNONYM: TRADD, TNFR1-ASSOCIATED DEATH DOMAIN PROTEIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PRSETB KEYWDS TNFR-1 ASSOCIATED PROTEIN, APOPTOSIS EXPDTA SOLUTION NMR MDLTYP MINIMIZED AVERAGE AUTHOR D.TSAO,T.MCDONAUGH,K.MALAKIAN,G.-Y.XU,J.-B.TELLIEZ,H.HSU,L.-L.LIN REVDAT 5 16-FEB-22 1F2H 1 REMARK REVDAT 4 24-FEB-09 1F2H 1 VERSN REVDAT 3 01-APR-03 1F2H 1 JRNL REVDAT 2 01-AUG-01 1F2H 1 REMARK REVDAT 1 30-MAY-01 1F2H 0 JRNL AUTH D.H.TSAO,T.MCDONAGH,J.B.TELLIEZ,S.HSU,K.MALAKIAN,G.Y.XU, JRNL AUTH 2 L.L.LIN JRNL TITL SOLUTION STRUCTURE OF N-TRADD AND CHARACTERIZATION OF THE JRNL TITL 2 INTERACTION OF N-TRADD AND C-TRAF2, A KEY STEP IN THE TNFR1 JRNL TITL 3 SIGNALING PATHWAY. JRNL REF MOL.CELL V. 5 1051 2000 JRNL REFN ISSN 1097-2765 JRNL PMID 10911999 JRNL DOI 10.1016/S1097-2765(00)80270-1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER ET AL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES DETERMINED FROM 2402 REMARK 3 RESTRAINTS (1883 NOE RESTRAINTS, 159 DIHEDRAL, 100 DISTANCE REMARK 3 RESTRAINTS FROM HYDROGEN BONDS AND 240 ALPHA AND BETA 13C REMARK 3 CHEMICAL SHIFTS). REMARK 4 REMARK 4 1F2H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUN-00. REMARK 100 THE DEPOSITION ID IS D_1000011162. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298; 298 REMARK 210 PH : 6.6; 6.6; 6.6 REMARK 210 IONIC STRENGTH : 200MM NACL; 200MM NACL; 200MM REMARK 210 NACL REMARK 210 PRESSURE : 1 ATM; 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 1.0 MM 15N N-TRADD; 1.1 MM REMARK 210 15N/13C N-TRADD; 0.8 MM 15N/13C REMARK 210 N-TRADD REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY; HNHA; HNCACB; REMARK 210 HN(CO)CACB; C(CO)NH-TOCSY; REMARK 210 HCCHTOCSY; HAHB(CO)NH; 15N- REMARK 210 EDITED TOCSY-HSQC; METHYL-METHYL REMARK 210 NOE REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : UNITYPLUS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : DISTANCE GEOMETRY/SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOW ENERGIES AND VIOLATIONS NOT REMARK 210 LARGER THAN 0.3A FOR NOES AND 5 REMARK 210 DEGREES FOR TORSIONAL RESTRAINTS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: OTHER EXPERIMENTS USED WERE HC(CO)NH_TOCSY, 3D 13C-13C REMARK 210 LONG RANGE CORRELATION, METHYL-METHYL NOE REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 9 65.00 39.46 REMARK 500 ASP A 68 -169.00 46.31 REMARK 500 CYS A 78 -44.02 -155.22 REMARK 500 LEU A 107 -79.34 -89.97 REMARK 500 ALA A 108 34.50 -167.32 REMARK 500 SER A 111 124.57 -178.05 REMARK 500 REMARK 500 REMARK: NULL DBREF 1F2H A 1 169 UNP Q15628 TRADD_HUMAN 1 169 SEQRES 1 A 169 MET ALA ALA GLY GLN ASN GLY HIS GLU GLU TRP VAL GLY SEQRES 2 A 169 SER ALA TYR LEU PHE VAL GLU SER SER LEU ASP LYS VAL SEQRES 3 A 169 VAL LEU SER ASP ALA TYR ALA HIS PRO GLN GLN LYS VAL SEQRES 4 A 169 ALA VAL TYR ARG ALA LEU GLN ALA ALA LEU ALA GLU SER SEQRES 5 A 169 GLY GLY SER PRO ASP VAL LEU GLN MET LEU LYS ILE HIS SEQRES 6 A 169 ARG SER ASP PRO GLN LEU ILE VAL GLN LEU ARG PHE CYS SEQRES 7 A 169 GLY ARG GLN PRO CYS GLY ARG PHE LEU ARG ALA TYR ARG SEQRES 8 A 169 GLU GLY ALA LEU ARG ALA ALA LEU GLN ARG SER LEU ALA SEQRES 9 A 169 ALA ALA LEU ALA GLN HIS SER VAL PRO LEU GLN LEU GLU SEQRES 10 A 169 LEU ARG ALA GLY ALA GLU ARG LEU ASP ALA LEU LEU ALA SEQRES 11 A 169 ASP GLU GLU ARG CYS LEU SER CYS ILE LEU ALA GLN GLN SEQRES 12 A 169 PRO ASP ARG LEU ARG ASP GLU GLU LEU ALA GLU LEU GLU SEQRES 13 A 169 ASP ALA LEU ARG ASN LEU LYS CYS GLY SER GLY ALA ARG HELIX 1 1 VAL A 27 TYR A 32 1 6 HELIX 2 2 HIS A 34 GLY A 53 1 20 HELIX 3 3 GLY A 79 ALA A 108 1 30 HELIX 4 4 ARG A 124 ASP A 131 1 8 HELIX 5 5 ASP A 131 GLN A 142 1 12 HELIX 6 6 ASP A 149 LYS A 163 1 15 SHEET 1 A 4 MET A 61 SER A 67 0 SHEET 2 A 4 GLN A 70 ARG A 76 -1 N GLN A 70 O SER A 67 SHEET 3 A 4 SER A 14 GLU A 20 -1 O ALA A 15 N LEU A 75 SHEET 4 A 4 GLN A 115 ARG A 119 -1 N GLN A 115 O GLU A 20 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000